semaglutide cardiovascular outcomes news 2025 currently not cost-effective for heart patients without diabetes, study finds Wegovy confers reductions in cardiovascular – Semaglutide and Cardiovascular Outcomes in

Medical Expert, The gastroparesis symptoms are side effects of GLP-1s

Our Functional Medicine Experts understand that what's optimal for you might differ from a generalized "normal." We utilize a unique reference range to assess your optimization, aiming for your best possible health

Keep track of your bodys responses such as energy levels, mood fluctuations, and weight changesso that youre well-informed during check-ins with your healthcare provider

Guo Z, Lin J, Sun K, Guo J, Yao X, Wang G

Mild tenderness resolving within minutes is normal, but persistent or worsening pain requires clinical evaluation

This administrative gatekeeping disproportionately affects people who could benefit most from GLP-1 therapy